Note 13 - Segment and Geographic Information

9 Months Ended

Sep. 30, 2014

Segment Reporting [Abstract]

Segment Reporting Disclosure [Text Block]

 13.  Segment and Geographic Information

The Company has one reportable operating segment, the results of which are disclosed in the accompanying unaudited condensed consolidated financial statements.

Product revenue by product group is as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2014		2013		2014		2013
Orthobiologics	$	18,899,873	$	12,830,566	$	48,750,277	$	40,620,339
Dermal		401,355		267,766		938,966		1,066,409
Surgical		1,452,946		1,136,248		4,581,496		3,955,134
Ophthalmic		366,138		1,425,609		938,134		2,818,407
Veterinary		855,000		1,363,157		2,385,000		3,124,953
	$	21,975,312	$	17,023,346	$	57,593,873	$	51,585,242

Total revenue by geographic location and as a percentage of overall total revenue, for the three and nine-month periods ended September 30, 2014 and 2013 are as follows;

	Three Months Ended September 30,
	2014					2013
	Total Revenue		Percentage of Revenue			Total Revenue		Percentage of Revenue
Geographic Location:
United States	$	18,455,167		84	%	$	14,485,821		82	%
Europe		1,784,414		8	%		1,656,656		9	%
Other		1,815,842		8	%		1,611,961		9	%
Total	$	22,055,423		100	%	$	17,754,438		100	%

	Nine Months Ended September 30,
	2014					2013
	Total Revenue		Percentage of Revenue			Total Revenue		Percentage of Revenue
Geographic Location:
United States	$	72,935,722		89	%	$	42,251,336		78	%
Europe		5,274,071		6	%		5,226,619		10	%
Other		4,130,577		5	%		6,351,871		12	%
Total	$	82,340,370		100	%	$	53,829,826		100	%